Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

A pathology partnership
June 2020
SHARING OPTIONS:

WILMINGTON, Mass. & DUBLIN—Charles River Laboratories International Inc. and Deciphex have launched a partnership that looks to bring digital pathology to the realm of drug discovery and development. Deciphex’s Patholytix Preclinical platform combines ergonomic digital pathology workflows and artificial intelligence to enable primary diagnostic or peer-review results from a user’s workstation. Under this deal, Charles River will be the exclusive CRO distributing Patholytix Preclinical to clients, and the partners will co-develop deep learning-enabled tools for accelerated pathology analytics.
 
“Charles River offers the most robust preclinical pathology program in the industry. By partnering with their team, the use of the Deciphex technology will provide an incredible opportunity to positively influence the outcome of a significant component of the industry’s preclinical pathological samples,” said Donal O’Shea, founder and CEO of Deciphex.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.